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ABSTRACT
Lens epithelium-derived growth factor/p75 (LEDGF/
p75) is a transcriptional coactivator involved in
stress response, autoimmune disease, cancer and
HIV replication. A fusion between the nuclear pore
protein NUP98 and LEDGF/p75 has been found in
human acute and chronic myeloid leukemia and as-
sociation of LEDGF/p75 with mixed-lineage
leukemia (MLL)/menin is critical for leukemic trans-
formation. During lentiviral replication, LEDGF/p75
tethers the pre-integration complex to the host
chromatin resulting in a bias of integration into
active transcription units (TUs). The consensus
function of LEDGF/p75 is tethering of cargos to
chromatin. In this regard, we determined the
LEDGF/p75 chromatin binding profile. To this
purpose, we used DamID technology and focused
on the highly annotated ENCODE (Encyclopedia of
DNA Elements) regions. LEDGF/p75 primarily binds
downstream of the transcription start site of active
TUs in agreement with the enrichment of HIV-1 in-
tegration sites at these locations. We show that
LEDGF/p75 binding is not restricted to stress
response elements in the genome, and correlation
analysis with more than 200 genomic features
revealed an association with active chromatin
markers, such as H3 and H4 acetylation, H3K4
monomethylation and RNA polymerase II binding.
Interestingly, some associations did not correlate
with HIV-1 integration indicating that not all
LEDGF/p75 complexes on the chromosome are
amenable to HIV-1 integration.
INTRODUCTION
Lens epithelium-derived growth factor p75 (LEDGF/p75)
was ﬁrst described as a transcriptional coactivator and a
component of the general RNA polymerase II transcrip-
tion machinery (1). LEDGF/p75 protects cells against oxi-
dative stress by activation of stress response genes through
interaction with stress response elements, and
caspase-mediated cleavage of LEDGF/p75 is known to
disrupt or reverse this protection (2–6). In addition to
mediating stress response, LEDGF/p75 plays a crucial
role in cancer (7). Through its interaction with
mixed-lineage leukemia (MLL/menin), LEDGF/p75 is
involved in MLL-dependent transcription and leukemic
transformation. In agreement, NUP98-LEDGF/p75
fusions were found in human acute and chronic myeloid
leukaemia (8–11). LEDGF/p75 is also frequently encoun-
tered as an autoantigen in a subset of patients with atopic
disorders, mainly atopic dermatitis, and other inﬂamma-
tory conditions although its function as a potential cause
or outcome is not understood (12). It remains to be shown
whether the roles of LEDGF/p75 in stress response,
cancer and as an autoantigen are interrelated.
A shorter splice variant, p52, is expressed from the same
gene as LEDGF/p75 (PSIP1 in humans). While the
N-terminal 325 amino acids are identical, LEDGF/p75
has a unique C-terminal region of 205 amino acids.
Based on the conserved N-terminal PWWP domain,
both isoforms are classiﬁed as Hepatoma-derived growth
factor-related proteins (HRPs). Together with the
AT-hooks and the nuclear localization signal found in
the N-terminal part of the protein, the PWWP domain
tethers LEDGF/p75 to the chromatin (13,14). The
C-terminal moiety of LEDGF/p75 contains the integrase
binding domain. Next to binding cellular proteins like
JPO2, pogZ, menin/MLL and Cdc7-ASK (7,15–18), this
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of human immunodeﬁciency virus type 1 (HIV-1) and
other lentiviruses (19–24). HIV-1 integration into the
host cell genome displays a strong bias towards active
genes, disfavoring promoter regions and CpG islands
(25–28). Knockdown or knockout of LEDGF/p75
abolishes this integration pattern, supporting the hypoth-
esis that LEDGF/p75 binds active genes and tethers the
HIV pre-integration complex to these sites via its inter-
action with integrase (27,29,30). Contradictory to this,
cell biology data on LEDGF/p75 predict promoter asso-
ciation (4,6,31,32). To ﬁnd an answer to this discrepancy,
we mapped chromatin binding of LEDGF/p75 by DamID
technology and showed that this proﬁle is reminiscent of
that of HIV-1 integration. LEDGF/p75 binds active genes
disfavoring promoter regions. Correlation with more than
200 genomic features reveals an association with markers
of active chromatin. Intriguingly, some markers associate
with LEDGF/p75 binding but not with HIV-1 integration
suggesting that not all LEDGF/p75 chromatin inter-
actions are amenable to HIV-1 integration.
MATERIALS AND METHODS
Lentiviral vector plasmid construction and vector
production
The lentiviral transfer plasmid pLgw-EcoDam-V5-MCS
was a kind gift from Dr Bas van Steensel (The
Netherlands Cancer Institute, NKI, the Netherlands)
and encodes C-terminally V5-tagged Escherichia coli
Dam methylase (EcoDam) under the control of the HSP
(heat shock protein) promoter. The LEDGF/p75 coding
region was PCR-ampliﬁed using primers F: 50-ggg gac aag
ttt gta caa aaa agc agg ctt cac tcg cga ttt caa acc tgg-30 and
R: 50- ggg gac cac ttt gta caa gaa agc tgg gtc cta gtt atc tag
tgt aga atc c-30 (Invitrogen Gateway recombination
region in italics and LEDGF/p75 homology region
underlined) and cloned N-terminally to the V5-EcoDam
according to the manufacturer’s protocol (Invitrogen,
Merelbeke, Belgium) yielding plasmid pLgw-EcoDam-
V5-LEDGF/p75. The integrity of the construct was
veriﬁed by DNA sequencing. Lentiviral vectors were
prepared as described previously (33). The
pLNCLEDGF/p75-IRES-Bsd and pLNCLEDGF/
p75D366A-IRES-Bsd plasmids for rescue of HIV replica-
tion were described before Ref. (34).
Cell culture and transient transfection
HeLaP4 and 293T cells were grown in Dulbecco’s
modiﬁed Eagle’s medium (DMEM) (Gibco-BRL,
Merelbeke, Belgium) supplemented with 10% fetal calf
serum (Sigma, Bornem, Belgium) and 20mg/ml gentamicin
(Gibco-BRL) (further referred to as DMEM complete) at
37 C and 5% CO2 in a humidiﬁed atmosphere. For
western blotting 5 10
5 293T cells were transfected
using 3mg of plasmid DNA complexed with lipofectamin
as described by the manufacturer (Invitrogen) and
incubated overnight. HeLa CCR5 A3 cells with a stable
LEDGF/p75 knockdown were described before Ref. (34).
Fluorescence laser scanning microscopy
Cells were grown in LabTek II glass chamber slides (VWR
International, Haasrode, Belgium) and transfected after
24h with pmRFP-IN (35) and pLgw-EcoDam-V5-
LEDGF/p75 or pLNC LEDGF/p75-IRES-Bsd. The
24-h post-transfection cells were ﬁxed with 4% formalde-
hyde in PBS for 10min. Immunohistochemistry staining
of endogenous LEDGF/p75 was performed using rabbit
anti-LEDGF/p75 antibody (Bethyl, Montgomery, TX,
USA). EcoDam-LEDGF/p75 fusion protein was
detected using mouse anti-V5 antibody (Sigma). Alexa
488-labelled secondary antibodies were used for detection.
Nuclear DNA was stained with 0.5mg/ml DAPI
(Molecular Probes, Merelbeke, Belgium). Confocal mi-
croscopy was performed using an LSM 510 meta unit
(Zeiss, Zaventem, Belgium). All images were acquired in
the multi-track mode. Alexa 488 was excited at 488nm (by
AI laser), mRFP at 543nm (by HeNe laser) and DAPI at
790nm (by Spectra-Physics Mai Tai laser). After the main
beam splitter (HFT KP 700/543 for mRFP, HFT UV/488/
543/633 for eGFP and HFT KP650 for DAPI) the ﬂuor-
escence signal was divided by a secondary dichroic beam
splitter (NFT 490 for eGFP and NFT 545 for mRFP) and
detected in the separate channels using the appropriate
ﬁlters (BP 500–-550 for Alexa 488, BP 565–615 for
mRFP and BP 435–485 for DAPI).
Western blotting
Protein samples were separated on 10% SDS–PAGE and
electroblotted onto polyvinylidene diﬂuoride membranes
(PVDF; Bio-Rad). Membranes were blocked with milk
powder in PBS/0.1% Tween20 and detection was carried
out using mouse anti-V5 antibody (Sigma-Aldrich).
Visualization was performed using chemiluminescence
(ECL+, Amersham, Diegem, Belgium) using anti-mouse
antibodies coupled to HRP (Dako, Denmark).
DamID and DNA tiling array hybridization
Expression of the EcoDam-LEDGF/p75 fusion protein
and the EcoDam-only control protein and preparation
of gDNA was performed essentially as described (36).
Brieﬂy, 5 10
5 HeLaP4 cells were plated in six-well
dishes. The next day, three wells each were transduced
overnight with 1.5ml of a lentivector preparation
(12.5 10
3pg p24/ml) expressing either EcoDam-
LEDGF/p75 or EcoDam-only under the control of the
HSP promoter or left untreated. After transduction, the
medium was replenished and cells were allowed to grow
for 48h under normal cell culture conditions (37 C, 5%
CO2, DMEM complete). After 48h, cells were collected by
trypsinization and gDNA was prepared using the
GenElute Mammalian Genomic DNA puriﬁcation kit
(Sigma-Aldrich) according to the manufacturer’s
protocol. Ampliﬁcation of methylation-speciﬁc PCR frag-
ments was performed as described (36) with minor modi-
ﬁcations to comply with the hybridization protocol of the
Aﬀymetrix ENCODE 2.0R tiling arrays. For this purpose,
PCR ampliﬁcations were performed in the presence of
dNTP (25mM each) and dUTP (5mM). This allowed
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ments into fragments of  66bp using UDG/APE
enzymes. The correct length of the fragments was con-
ﬁrmed by electrophoresis using the Agilent Bioanalyzer
(Agilent, Diegem, Belgium). Three biological replicates
of EcoDam-LEDGF/p75 and EcoDam-only samples
each were hybridized with Aﬀymetrix GeneChip
ENCODE 2.0R DNA tiling microarrays (Aﬀymetrix,
Santa Clara, CA, USA) and subsequently analyzed ac-
cording to the manufacturer’s protocol.
DamID analysis
The MAT (Model-based Analysis of Tiling arrays) algo-
rithm was used to identify genomic regions of statistically
signiﬁcant enrichment of LEDGF/p75 binding (EcoDam-
LEDGF/p75 versus EcoDam-only samples) (37). For each
array, MAT linearly ﬁts the baseline probe behavior in
function of the probe sequence and copy number and
uses this model to standardize the readout t-value for
each probe. A sliding window approach was used to
deﬁne enriched regions (BandWidth: 300bp; MaxGap:
300bp; MinProbe; 10; signiﬁcance cut-oﬀ P<10
 5).
Other parameters or algorithms (TAS, Tiling Analysis
Software; Aﬀymetrix) were also tested and yielded
similar results (See also Supplementary Figure S1). The
MAT score amounts to the average t-value in the
probe-centered window and across replicates after
trimming of the upper and lower t-value deciles,
multiplied by the square root of the number of observa-
tion points the MAT score is based on. The control MAT
score was subtracted from that for LEDGF/p75.
Signiﬁcantly enriched regions were recorded in .bed
format for further analysis.
Data analysis
The RefSeq data set and all Encyclopedia of DNA
Elements (ENCODE) data sets were obtained from the
UCSC website (http://genome.ucsc.edu/). The HIV-1 inte-
gration set was downloaded from the Bushman Lab
website (http://microb230.med.upenn.edu/) (28). All data
analysis was performed with in-house-written Python
scripts (http://www.python.org/). To determine the distri-
bution of LEDGF/p75 in transcription units (TUs), each
base of a LEDGF/p75 island was given the overall island
score. This score was divided into bins according to their
relative distance to the transrciption start site (TSS). If
two TUs overlapped in the opposite strand, the same
score was added to both bins. If two or more TUs
overlapped in the same strand, the weight of the score
was divided by the number of TUs and put in its corres-
ponding bin. An identical approach was followed for the
HIV integration sites. In this case, each integration site
received a unit weight. To analyze the distribution of
LEDGF/p75 around the TSS the same approach was
used. In case an LEDGF/p75 positive base was inside
one TU and directly upstream of a second TU, the
weight of a base was assigned to the former TU since
LEDGF/p75 islands do not overlap with TSSs.
Correlation with transcriptional activity
Two publicly available HG-U133A Aﬀymetrix HeLa cell
line expression array data sets (GSM156764 from data set
GSE9750 and GSM156764 from data set GDS2623) were
obtained from the NCBI GEO data set browser (www.
ncbi.nlm.nih.gov/geo/). Model-based expression index
(MBEI) values were calculated as a measure of the
average expression level of individual genes in HeLa
cells using the dCHIP algorithm for the combined data
sets (38). For each represented gene, the highest expression
index was included for further analysis. Genes present in
the ENCODE regions were subsequently binned in
function of their expression level and the percentage of
LEDGF/p75 containing genes was calculated for each bin.
Cross-correlation with ENCODE regions
To calculate the cross-correlation curves between an
ENCODE track of interest and the LEDGF/p75 track,
the LEDGF/p75 track was shifted along the ENCODE
track from  10kb to +10kb and the cross-correlation
was calculated for each 250 bases (lags) (See Supple-
mentary Figure S3). For cross-correlation with the
HIV-1 integration sites, the integration data were
blurred to the mean size of the LEDGF/p75 island with
scores declining from the island center to the borders. To
test for signiﬁcance, 600 random LEDGF/p75 and inte-
gration tracks of equal size as the observed tracks were
generated. To generate random LEDGF/p75 islands
tracks, islands of the same size and MAT score were
picked at a randomly chosen location in the ENCODE
region. To generate the matched HIV-1 integration site
tracks for each experimental integration site at an
observed distance from the cloning restriction site, a
control site was selected within the ENCODE regions at
the same distance of a randomly chosen restriction site.
The 2.5 through 97.5 percentile interval for control
Pearson’s cross-correlation coeﬃcients with the
ENCODE track of interest was calculated at lag 0.
Coeﬃcients of random tracks at lower or higher lags did
not statistically diﬀer from lag 0 in a few representative
trials and were further omitted to minimize processing
time.
Cytological analysis of HeLaP4 and Jurkat cells
Genomic DNA from Jurkat, HeLaP4 and from peripheral
blood mononuclear cells from a healthy individual were
extracted and labeled with Cy5 or Cy3 using the Bioprim
Labeling kit (Invitrogen) according to the manufacturer’s
protocol. Probes were hybridized on Syndrome Plus v2
array chips (Oxford Gene Technology, Yarnton, UK)
using the Oligo aCGH hybridization kit (Agilent) accord-
ing to the manufacturer’s protocol. Chips were scanned on
an Agilent microarray scanner and analyzed using Agilent
Feature Extraction software and Cytosure software
(Oxford Gene Technology). Cy5-labeled Jurkat or
HeLaP4 DNA was analyzed together with Cy3-labeled
control DNA on the same chip. The analysis for each
cell line was repeated with switched dyes.
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Expression and functional validation of the
EcoDam-LEDGF/p75 fusion protein
To determine the LEDGF/p75 chromatin interaction
proﬁle we used DamID technology, which relies on the
expression of a fusion between the EcoDam and a chro-
matin binding protein of interest (36,39). Chromatin
binding results in methylation of neighboring GATC
sites that are speciﬁcally ampliﬁed. The resulting probes
are used for microchip analysis. Expression of the
EcoDam-LEDGF/p75 fusion protein is driven by an in-
ducible HSP promoter and encoded in a lentiviral vector
(Figure 1A). Stable HeLaP4 cells were generated (referred
to as HeLaP4 EcoDam-LEDGF/p75) together with an
EcoDam cell line (HeLaP4 EcoDam) to control for
aspeciﬁc methylation. Under normal cell culture condi-
tions (37 C), the HSP promoter hardly supports expres-
sion of the EcoDam-LEDGF/p75 fusion or EcoDam
protein. Low expression minimizes aspeciﬁc chromatin
binding and limits the eﬀect of the exogenous protein on
the cellular environment. Accordingly, expression in these
cell lines was undetectable via immunocytochemistry or
western analysis (data not shown). However, transient
transfection of lentivector transfer plasmids could
conﬁrm expression of EcoDam-LEDGF/p75 and
EcoDam by western blot analysis (Figure 1B). EcoDam-
LEDGF/p75 displayed the typical, dense, ﬁne-speckled
subnuclear distribution pattern of wild-type LEDGF/p75
as observed by confocal microscopy (Figure 1C).
Figure 1. The EcoDam-LEDGF/p75 fusion protein behaves like endogenous LEDGF/p75. (A) Schematic representation of the
pLgw-EcoDam-V5-LEDGF/p75 transfer plasmid expressing the EcoDam-V5-LEDGF/p75 fusion protein, and the pLgw-EcoDam-V5 transfer
plasmid expressing the EcoDam-V5 control protein. CMV, cytomegalovirus promoter; LTR, long terminal repeat; p75, LEDGF/p75. (B) 293T
cells were transiently transfected with the respective transfer plasmids. Total cell lysate was prepared and analyzed by western blotting using an
anti-V5 antibody. (C) HeLa CCR5 A3 cells depleted for LEDGF/p75 (34) were transfected with a LEDGF/p75 (upper panels, green) or an
EcoDam-V5-LEDGF/p75 expression plasmid (lower panels, green) together with an mRFP-integrase expression plasmid (red). DAPI was used to
stain the DNA. An overlay of the green and red panels is shown. (D) HIV-1 replication is rescued by the EcoDam-LEDGF/p75 fusion protein. HeLa
CCR5 A3 cells were transfected with the indicated constructs. The 24-h post-transfection cells were infected with two dilutions of an HIV-1 clone
encoding ﬁreﬂy luciferase (NL4.3 fLuc) (dark and light gray). Luciferase expression was measured 48h post-infection. Fluc counts upon transfection
of a control plasmid encoding an EcoDam fusion to CBX1 (51) were subtracted. LEDGF/p75 D366A, HIV integrase interaction deﬁcient LEDGF/
p75 (40). The experiment was done in triplicate and repeated four times. A representative experiment is shown. Error bars indicate the SD of the
triplicate values.
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LEDGF/p75 co-localized with HIV-1 integrase (23). Full
functionality of the EcoDam-LEDGF/p75 fusion protein
was evidenced in an HIV-1 rescue experiment (Figure 1D).
HeLa CCR5 A3 cells stably depleted for LEDGF/p75 (34)
were back-complemented with the EcoDam-LEDGF/p75
expression construct. As a control, wild-type LEDGF/p75
and a non-interacting LEDGF/p75 mutant (D366A) (40)
were used to back-complement the cells. The EcoDam-
LEDGF/p75 fusion protein could rescue infection with
HIV-1 Fluc to the same extent as wild-type LEDGF/p75.
LEDGF/p75 associates with transcription units,
downstream of the transcription start site
LEDGF/p75 chromatin binding regions were determined
by hybridization to ENCODE DNA tiling arrays (41).
The ENCODE project characterized 44 regions covering
about 1% of the human genome, comprising loci of
speciﬁc interest, such as the HOXA cluster, together
with randomly selected regions. More than 200 speciﬁc
tracks have been published that record distribution of
various epigenetic modiﬁcations and transcription factor
binding sites in these regions, explaining our choice for
ENCODE in this study. The correlation of many of
these tracks with HIV-1 integration has been studied
before (28). We performed and validated three independ-
ent DamID experiments in HeLaP4 cells. The MAT algo-
rithm identiﬁed 644 LEDGF/p75 chromatin binding
islands from the combined data sets and corresponding
controls (37). Islands were heterogeneous with regard to
their size and LEDGF/p75 binding intensity (MAT score):
sizes ranged between 415 and 2941 bases, with an average
of 1025.03 and an SD of 361.43 bases; MAT scores varied
between 1.82 and 9.89, with a mean score of 3.18±1.05.
One by one comparison of the experiments showed an
overlap of ±50% of the islands (Supplementary Table
S1). Around 25% of the islands were common to all
three experiments and around 40% were unique.
Diﬀerent parameters were tested during MAT analysis
to deﬁne the LEDGF/p75 islands (See ‘Materials and
Methods’ section and Supplementary Figure S1).
Downstream analysis yielded the same results as the
LEDGF/p75 islands used in this article.
Random control sites were generated computationally.
Per experimental site 10 sites were computed, matched with
respect to the size and MAT score at a randomly chosen
location in the ENCODE region [matched random
control, (MRC)]. In the analyses that follow, the distribu-
tion of experimental LEDGF binding sites is compared to
that of the MRC sites. The total RefSeq TUs coverage of
ENCODE regions is 45.7%, which is about 10% higher
than for the whole genome. Seventy-ﬁve percent of the
LEDGF/p75 islands were found in RefSeq TUs as
compared to 47% of the MRC islands (Figure 2A).
Signiﬁcantly, fewer LEDGF/p75 islands (0.3%) than
random (1.5%) overlapped with the TSS (P<0.05,  
2-
test). Conversely, signiﬁcantly more LEDGF/p75 islands
(2.3%) than random (1.3%) coincided with the transcrip-
tion termination site (P<0.05,  
2-test). Similar results
were obtained for Ensembl TUs (Figure 2A). Given the
fact that many TUs overlap, we repeated the analysis for
the 268 non-overlapping genes in the ENCODE regions;
none of the LEDGF/p75 islands comprised a TSS (Figure
2A, non-overlap).
Taken together, these data demonstrate that LEDGF/
p75 preferentially associates with TU downstream of the
TSS. Interestingly, 86% of the HIV integration sites in the
ENCODE region were also located in a TU (28).
Signiﬁcantly, fewer RefSeq TUs were bound by
LEDGF/p75 (28.4%) than expected from MRC (37.9%)
(P<0.0001,  
2-test), suggesting that LEDGF/p75 prefer-
entially targets selected subsets of genes. However, gene
ontology analysis did not show signiﬁcantly favored or
disfavored functional GOstat categories in comparison
with all ENCODE genes (42). Furthermore, the
GIMSAM search engine failed to detect a binding site
that was signiﬁcantly enriched as compared to MRC (43).
To take a closer look at the distribution of LEDGF/p75
binding sites within TUs, LEDGF/p75 islands were
binned relative to their position in the TU and the cumu-
lative MAT score for each bin was plotted (Figure 2B).
The probability of LEDGF/p75 binding gradually de-
creases towards the transcription termination site. The
downward trend was also observed not taking into
account the MAT scores, but only the presence of
LEDGF/p75 (data not shown). Linear regression qualiﬁed
this negative trend as signiﬁcant (P<0.0001, Fisher’s z).
Analysis of the mean MAT score per bin or the distribu-
tion of island sizes over the TU did not show signiﬁcant
diﬀerences (P>0.1, Fisher’s z). This trend was not
observed for MRC islands too (P=0.13, Fisher’s z). As
a consequence, the amount of islands is signiﬁcantly
higher at the 50-site of TUs. Next, we binned MAT
scores in function of their absolute distance to the TSS
and plotted the MAT score sums for the bins within
10kb around the TSS. The probability of LEDGF/p75
binding is low upstream of the TSS (Figure 2C), but
rises steeply immediately downstream of the TSS.
Wherever islands mapped to multiple, partially
overlapping genes, we preferentially assigned islands to
genes that completely encompass the island, because un-
equivocally assigned LEDGF/p75 islands almost never
include a TSS. As a consequence, the MAT score sums
of the MRC islands also increased downstream of the
TSS. Importantly, while the proﬁles are similar upstream
of the TSS and near the TSS, the rise of the LEDGF/p75
proﬁle downstream of the TSS is about three times higher
than that of MRC, again indicating an enrichment of
LEDGF/p75 downstream of the TSS. Since the probabil-
ity of LEDGF/p75 binding decreases towards the tran-
scription termination site, LEDGF/p75 binding around
the transcriptional end was indistinguishable from MRC
(Figure 2D). In conclusion, LEDGF/p75 preferentially as-
sociates with chromatin downstream of the TSS and
binding decreases towards the transcriptional end.
LEDGF/p75 chromatin binding correlates with
transcriptional activity of the transcriptional unit bound
HIV-1 integration correlates positively with transcription-
al activity of the targeted TU (26). To study a possible
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the NCBI GEO data set) and LEDGF/p75 chromatin
binding, ENCODE genes were binned in function of
their transcriptional activity and the percentage of
LEDGF/p75 positive genes for each bin was calculated
(Figure 3). LEDGF/p75 binding was shown to correlate
signiﬁcantly with gene activity (multinomial Fisher’s exact
test, P<0.05), while no correlation was demonstrated for
the MRC (P=0.8).
HIV-1 integration is targeted to LEDGF/p75 chromatin
binding islands
HIV-1 integration is targeted to active TUs, and
knockdown or knockout of LEDGF/p75 has been
reported to disrupt this targeting preference (27,29,30),
suggesting a direct role for LEDGF/p75 in HIV-1 target-
ing. In addition, by replacement of the N-terminal chro-
matin binding domains of LEDGF/p75 by alternative
chromatin binding domains, retargeting of viral integra-
tion was recently achieved (34,44,45). More than
800 HIV-1 integration sites were identiﬁed in ENCODE
regions in Jurkat T cells (28). A quantitative model that
predicts HIV-1 integration sites based on genomic features
determined several ENCODE regions to contain more or
less integration sites than expected (28,46). For instance,
ENCODE region ENm014 on Chromosome 7 carries
Figure 2. LEDGF/p75 binds TUs downstream of the TSS. (A) Distribution of LEDGF/p75 islands around TUs. The percentage of LEDGF/p75
islands in TUs and overlapping with TSS or transcription ends is shown for RefSeq and Ensembl TUs and for non-overlapping RefSeq TUs. As a
control, a random data set of LEDGF/p75 islands was generated 10 times the size of the original data set (MRC). *P<0.05, **P<10
 27 as
compared to random as measured by a  
2-test. (B) LEDGF/p75 binding in TUs was plotted relative to the TSS (LEDGF/p75). All genes were
divided in 20 equal bins and the MAT score of each LEDGF/p75 positive base was assigned to the corresponding bin. For each LEDGF/p75 island,
10 new islands were picked at a random position within the ENCODE region having the same size and score as the parental island (MRC). As for
LEDGF/p75 islands, the random islands were plotted relative to the TSS. Values were divided by 10 for comparison with the LEDGF/p75 islands.
HIV-1 integration sites in TUs (28) were assigned to the corresponding bin relative to the TSS (HIV integration). If LEDGF/p75 or integration sites
could be assigned to more than one TU, the weight was divided over all TUs. (C) Distribution of LEDGF/p75, MRC and HIV-1 integration sites
around the TSS. Scores for LEDGF/p75 and random islands were accumulated for each base in a 20kb window around the TSS. All TUs were
analyzed in 50–30 orientation. Data values of the random curve were divided by 10 to be comparable with LEDGF/p75 islands. For HIV-1
integration sites, the 20kb window was divided into 1-kb bins. Each integration site was assigned to the corresponding bin. Since LEDGF/p75
islands almost never overlap with the TSS, a positive base found in the TU was fully assigned to this TU and not divided over potential neighboring
units. (D) Distribution of LEDGF/p75, random islands (MRC) and HIV-1 integration sites around the transcriptional end. Analysis was performed
as described in C.
Figure 3. LEDGF/p75 chromatin binding correlates with transcrip-
tional activity. Genes in the ENCODE region were divided into bins
according to their expression level. The percentage of LEDGF/p75
positive genes in each bin is shown in black. The 95% conﬁdence
interval is shown (gray shading). As a control, 10 MRC sets of equal
size as the original data were computed and divided over the bins (gray
line). The mean±SD is shown.
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(ZNF800; Figure 4A). Strikingly, we also found a major
cluster of LEDGF/p75 islands in ZNF800. For a more
exhaustive study of the association of HIV-1 integration
sites and LEDGF/p75 chromatin binding sites, we
generated MRC integration sites (HIV MRC). To this
end, for each experimental integration site at an
observed distance from the cloning restriction site, 10
control sites were computed within the ENCODE
regions each at the same distance of randomly chosen re-
striction sites. This approach controls for recovery bias
due to cleavage by restriction enzymes (46,47). Of 861
HIV-1 integration sites, 4.65% were found in the
LEDGF/p75 islands, as compared to only 2.43±0.45%
of the HIV MRC sites (P<0.01, Fisher’s exact test). We
then assigned HIV integration sites to the nearest
LEDGF/p75 island and computed the percentage of inte-
grations within absolute distance bins from the center of
the LEDGF/p75 islands (Figure 4B). Zooming in on the
center of LEDGF islands (<3.5kb from the center),
HIV-1 integrates three times more frequently near the
center of LEDGF/p75 islands than HIV MRC. Beyond
3.5kb from the island center, the enrichment attenuates
and becomes indistinguishable from that of HIV MRC,
around 10kb from the center. Since the HIV integration
data and the LEDGF/p75 chromatin binding data were
obtained in two diﬀerent cell lines, possible biases due to a
diﬀerent expression proﬁle or diﬀerent chromosomal
content of the cells had to be controlled for. To analyze
whether diﬀerent expression levels could inﬂuence the
results, HeLa and Jurkat expression proﬁles were
derived from the NCBI GEO data set and compared.
Chromatin regions with genes showing more than
10-fold diﬀerence in expression were omitted from the
analysis. Also, for this data set, integration preferentially
took place in the neighborhood of LEDGF/p75 islands,
ruling out that observed diﬀerences were due to diﬀerent
expression proﬁles (Supplementary Figure S2a). To
analyze the status of the ENCODE regions in Jurkat
and HeLaP4 cells, genomic DNA was extracted and
analyzed on OGT Syndrome Plus v2 array chips. These
chips are especially designed to detect genome-wide
chromosomal aberrations. The results showed that
Jurkat cells are near diploid. Only one of the 44
ENCODE regions contained a small deletion. HeLa cells
contain more chromosomal aberrations although at least
one copy of all ENCODE regions was present. Fourteen
out of 44 ENCODE regions showed duplications or dele-
tions in one allele. As most of these regions seemed to be
mosaic, it was impossible to determine an exact copy
Figure 4. HIV-1 integration is targeted to LEDGF/p75 chromatin binding islands. (A) Schematic representation of LEDGF/p75 islands and HIV-1
integration sites in ENCODE region ENm014 (http://genome.ucsc.edu/). This ENCODE region contains signiﬁcantly less integration sites than
predicted (28). All integration events took place around the same TU that also contains LEDGF/p75 islands. GCC1, GRIP and coiled-coil domain
containing 1; ARP5, actin-related protein 5 homolog; FSCN3, fascin 3. (B) The region surrounding the middle of LEDGF/p75 islands was divided in
0.5kb bins. Integration sites were assigned to the closest LEDGF/p75 island and placed into the corresponding bin. The percentage of integration
sites in each bin is shown (bold line). Ten data sets of matched random integration sites (HIV MRC) of equal size as the HIV-1 integration data set
were generated and assigned to the corresponding bin (light line). The SD is shown.
Nucleic Acids Research, 2010,Vol.38, No. 18 6141number. For this reason, we removed all non-diploid
ENCODE regions and reanalyzed the correlation
between HIV integration sites and LEDGF/p75 binding
(Supplementary Figure S2b). Also under these conditions,
the association of LEDGF/p75 with genuine HIV integra-
tion sites remained tighter than that with MRC integra-
tion sites.
Association of LEDGF/p75 with markers of active
transcription
The correlation of HIV-1 integration with ENCODE
tracks has been studied before (28). As a logical next
step, we performed a similar analysis for the LEDGF/
p75 chromatin binding sites. We quantiﬁed the
cross-correlation of the observed LEDGF/p75 binding
sites, known HIV-1 integration sites, and 600 MRC or
HIV MRC tracks with 215 ENCODE tracks (41).
Sixty-two tracks did not correlate diﬀerently with
LEDGF/p75 binding sites or the MRC; for 126 tracks a
signiﬁcantly positive and for 27 a signiﬁcantly negative
correlation was obtained. Likewise, HIV-1 integration
sites tallied, respectively 69, 125 and 21 tracks in these
categories. Sixty-two percent of the ENCODE tracks
scored signiﬁcant correlation coeﬃcients of the same
sign for LEDGF/p75 binding and HIV-1 integration
sites (green squares; Figure 5), and only 1.8% scored sig-
niﬁcant correlation coeﬃcients of the opposite sign. This
analysis corroborates the proposed role of LEDGF/p75 in
targeting of HIV-1 integration. An overview of all tracks
can be found in the Supplementary Data (Supplementary
Table S2). Cross-correlation enables comparison between
corresponding chromatin features, but also between
shifted ones as revealed by cross-correlation curves
(Supplementary Figure S3). As shown in Figure 6,
LEDGF/p75 binding correlated positively with markers
of euchromatin and transcriptional activation such as
H3 and H4 acetylation, H3K4 monomethylation and
RNA polymerase II binding, and negatively with deter-
minants of heterochromatin such as H3K27
trimethylation. Remarkably, although HIV-1 integration
also positively correlates with these markers of active tran-
scription as published before (28), HIV-1 integration
appeared to be scattered around the LEDGF/p75 peak
(Figure 6).
Diﬀerential association of LEDGF/p75 and HIV-1
integration with ENCODE tracks
Interestingly, some ENCODE tracks such as Stat1 (signal
transducer and activator of transcription), Hnf4a, Hnf3b
and Usf1 chromatin binding correlated strongly with
LEDGF/p75, but not with HIV-1 integration (Figure 7).
After viral induction of interferon-g, Stat1 is known to
translocate from the cytoplasm to the nucleus, where it
binds and activates target genes (48). Stat1 is strongly
associated with LEDGF/p75 binding but not with
HIV-1 integration (Figure 7, upper left panel). The same
goes for the functionally related transcription factors,
Hnf4a, Hnf3b and Usf1 (49), even though the coeﬃcient
of correlation of LEDGF/p75 with these factors is an
order of magnitude lower than that between Hnf3b and
Hnf4a or Usf1 (data not shown). These examples
document for the ﬁrst time that not all LEDGF/p75
complexes bound to chromatin are accessible for the
HIV-1 pre-integration complex to support integration or
that integration at these positions is restricted.
DISCUSSION
Research hints at a role of LEDGF/p75 in stress response
[See (12) and references therein]. LEDGF/p75 expression
is induced by oxidative stress and LEDGF/p75 itself is
believed to activate stress-related genes by binding stress
response and heat shock-related elements (4). In this work,
we deﬁned the LEDGF/p75 chromatin binding proﬁle in
the ENCODE region using DamID. DamID technology is
extensively used in Drosophila genomics and is as powerful
as ChIP-on-chip to determine chromatin binding proﬁles
(50). While the resolution is the same as for ChIP-on-chip
(1–2kb), DamID has the advantage that neither antibody
nor cross-linking is needed. Furthermore, expression of
the Dam fusion protein at extremely low level prevents
aspeciﬁc and saturating methylation levels, as well as dis-
turbance of the normal cellular physiology.
Analysis of the resulting LEDGF/p75 binding islands
revealed that 75% of LEDGF/p75 islands were located in
TUs although the promoter region itself was disfavored.
TUs are not enriched for ‘gatc’ sites as compared to the
whole ENCODE region (P<0.05, Mann–Whitney
U-test). Hence, enrichment of the LEDGF/p75 binding
islands within TUs cannot be attributed to the ‘gatc’ de-
pendence of the DamID technology, but is indicative of
Figure 5. Cross-correlation of LEDGF/p75 islands and HIV-1 integra-
tion with ENCODE tracks. Scatter plot of the correlation of each of
the 215 ENCODE tracks with LEDGF/p75 islands and HIV-1 integra-
tion sites. Signiﬁcance was tested by calculating the 2.5 through 97.5
percentile interval of Pearson’s correlation coeﬃcients for 600 HIV-1
and LEDGF/p75 matched random controls with each ENCODE track
of interest as described in the ‘Materials and Methods’ section. Most
ENCODE tracks with a positive correlation with HIV-1 integration,
positively correlate with LEDGF/p75 binding (in green). Black, no cor-
relation with HIV-1 or LEDGF/p75 track; orange, positive or negative
correlation with HIV-1 integration, no correlation with LEDGF/p75
binding; blue, positive or negative correlation with LEDGF/p75
binding, no correlation with HIV-1 integration; red, correlation of
the HIV-1 and LEDGF/p75 track with the ENCODE track have the
opposite sign.
6142 Nucleic Acids Research, 2010,Vol.38, No. 18Figure 6. Shifted cross-correlation of LEDGF/p75 islands and HIV-1 integration with ENCODE tracks. The Pearson’s correlation coeﬃcient
between LEDGF/p75 (black) or HIV-1 integration sites (gray) and the indicated ENCODE track was calculated for each lag. Lags indicate the
distance the LEDGF/p75 or HIV-1 integration track was shifted as compared to the ENCODE track of interest to calculate the cross-correlation
coeﬃcient. Both for LEDGF/p75 islands and HIV-1 integration sites, 600 random tracks of the same size were generated. The correlation coeﬃcient
at lag 0 of the depicted ENCODE track with each random track was calculated. The 2.5 through 97.5 percentile interval fell between the dashed lines
(black, LEDGF/p75; gray, HIV-1 integration sites). Histones 3 and 4 (H3 and H4) acetylation and Histone 3 Lysine 4 (H3K4) monomethylation are
epigenetic markers of active transcription. Histone 3 Lysine 27 (H3K27) trimethylation is a marker of heterochromatin.
Nucleic Acids Research, 2010,Vol.38, No. 18 6143genuine LEDGF/p75 enrichment in these regions.
LEDGF/p75 binds downstream of the TSS with a fre-
quency decreasing towards the end of the TU. These
results seem at odds with our current understanding of
the cellular function of LEDGF/p75, since an activator
of expression of stress response genes would be expected
to be enriched at promoter sites. Though some studies
indicated that LEDGF/p75 binds speciﬁc sequence
elements associated with the promoter regions of stress
response genes (4,6,31,32), others failed to detect
sequence-speciﬁc LEDGF/p75 binding activity in vitro
(14). It can however not be excluded that LEDGF/p75
binds stress response elements during stress conditions.
Of note, the ENCODE region does not contain
stress-responsive genes. A future DamID experiment
with stress-induced cells could shed light on this issue.
Nevertheless, at this stage our results demonstrate that
LEDGF/p75 chromatin binding is not limited to stress
response genes since it amounts to 28% of the
ENCODE RefSeq genes. Although the proportion of
LEDGF/p75-bound genes might be underestimated due
to the strict threshold used to analyze the microarray
data, this is signiﬁcantly less than the 37% for the corres-
ponding control set, suggesting that LEDGF/p75 targets
only a speciﬁc subset of genes. Though we have to take
into account the relatively small amount of genes present
in the ENCODE region, Gene Ontology analysis did not
support any signiﬁcant functional enrichment for certain
gene product characteristics. Twenty-ﬁve percent of the
LEDGF/p75 islands located outside of TUs. The mean
score and size of this fraction is indistinguishable from
that of all islands suggesting that these represent genuine
LEDGF/p75 islands. In addition, the mean distance of
this fraction to TUs does not diﬀer from random (data
not shown). The function of those islands remains to be
investigated. At this stage, one can only speculate that
these islands may have an important function in the es-
tablishment of latent lentiviral proviruses.
As expected and based on the known association
between LEDGF/p75 binding and HIV-1 integration,
the LEDGF/p75 chromatin interaction proﬁle is reminis-
cent of that of HIV-1 integration (28). Much alike HIV-1
Figure 7. Divergent cross-correlation of LEDGF/p75 islands and HIV-1 integration with speciﬁc ENCODE tracks. For an explanation of the
cross-correlation curves, see legend to Figure 6. The ENCODE tracks shown have a strong positive correlation with LEDGF/p75, but do not
correlate with HIV-1 integration. Stat1, signal transducer and activator of transcription; Hnf3b, hepatocyte nuclear factor 3-b; Hnf4a, hepatocyte
nuclear factor 4-a; Usf1, upstream transcription factor 1.
6144 Nucleic Acids Research, 2010,Vol.38, No. 18integration, LEDGF/p75 binding prefers the body of
genes, disfavoring the promoter regions and correlating
with transcriptional activity. Compared to 75% of the
LEDGF/p75 islands, 86% of the ENCODE
region-associated HIV integration sites were found in a
TU and 30% of all integration sites were found in a
window of 3.5kb around the center of an LEDGF/p75
island, which amounts to a more than 3-fold enrichment
over control integration sites. These data corroborate that
LEDGF/p75 plays a role in HIV-1 targeting. This
apparent window might however be inﬂuenced by the
resolution and sensitivity of the DamID technology.
Moreover, our DamID experiments were carried out in
HeLaP4 cells, while the integration data set was derived
from a Jurkat T cell line. Nevertheless, controlling our
analysis for diﬀerent expression proﬁles or chromosomal
content between both cell lines did not signiﬁcantly change
the obtained results.
The correlation of the majority of the more than 200
studied ENCODE tracks with the LEDGF/p75 binding
proﬁle often mirrors that of HIV integration [this article
and (28)]. Overall, LEDGF/p75 binding was associated
with markers of active transcription like H3 and H4
acetylation, H3K4 monomethylation and RNA polymer-
ase II binding, but correlated negatively with markers of
heterochromatin. The cross-correlation curves with
LEDGF/p75 binding sites revealed interesting patterns
and some striking diﬀerences with HIV integration sites.
In most cases, ENCODE tracks with a strong correlation
with LEDGF/p75 chromatin binding also showed a high
coeﬃcient of correlation with HIV integration. While the
correlation with LEDGF/p75 peaked over a relatively
small window, that with HIV integration was more
spread out around the LEDGF/p75 peak, in line with
the window of enrichment of HIV-1 integration straddling
LEDGF/p75 binding spots. These results indicate that the
DamID resolution is high enough for comparison of
LEDGF/p75 chromatin interaction with HIV integration
and again suggests that HIV integrates in the wide neigh-
borhood of LEDGF/p75 binding.
Interestingly, our data point out that not all chromatin
bound LEDGF/p75 supports eﬀective HIV integration.
Indeed, the transcription factors Stat1, Hnf4a, Hnf3b
and Usf1 correlated well with LEDGF/p75 binding but
not with HIV-1 integration. The chromatin binding
proﬁle of this integration incompatible LEDGF/p75
fraction is indistinguishable from that of the complete
LEDGF/p75 track (data not shown). HIV-1 integrase
interacts with the integrase binding domain of LEDGF/
p75, which is known to bind as well to other proteins like
Jpo2, pogZ, MLL/menin and Cdc7-ASK (7,15–18). It will
be of interest to verify whether the chromatin binding of
the LEDGF/p75 fraction that is incompatible for HIV
integration correlates with the binding proﬁle of one of
these alternative partners. Competition in the binding
with LEDGF/p75 may abrogate eﬃcient integration.
In conclusion, the LEDGF/p75 chromatin binding
proﬁle corroborates the previously claimed association
between LEDGF/p75 binding and HIV-1 integration.
Still, other determinants seem to play a role since not all
LEDGF/p75 sites support HIV integration, and
integration can occur at some distance from the actual
LEDGF/p75 chromatin interaction spot. Moreover, our
data challenge the current concept on the role of LEDGF/
p75 in cell metabolism. It is clear that the function of
LEDGF/p75 is not restricted to stress response. The
more general chromatin interaction proﬁle is compatible
with a global role in transcriptional regulation. Of note,
LEDGF/p75 was originally identiﬁed as a component of
the general transcriptional machinery (1). In this regard, it
will be of interest to analyze the expression and chromatin
interaction proﬁle of LEDGF/p75 in response to cellular
stress.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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